摘要
癌症和老化是两种相似的代表许多不可逆功能减退的时间相关累积的最后结果的进程,主要由压力诱导DNA和细胞损伤所造成。细胞凋亡和衰老是细胞对待癌症和老化的两种回应,即使通过不同的机制。致癌作用与细胞引发凋亡和衰老能力显著降低有关。相反的是,在老化的组织中,衰老细胞的累积会增加,细胞凋亡反常种类的天性依赖于组织。因此,普遍的模型认为细胞凋亡和衰老功能是两种潜在的肿瘤抑制机制,确保个体在早期和复制阶段的健康,但是在晚年时不利于人体并促进老化。不同的抗癌媒介,包括规范诱导的细胞凋亡,也诱导了细胞衰老,这一发现证明了促衰老战略可能应用于癌症防治治疗。因此,机制媒介在细胞凋亡和衰老间微妙平衡的详细研究将对治疗开发同时拥有抗癌和抗老化特征的战略有利,包括最小化这些战略的副作用。在此,我们综述了关于细胞凋亡和衰老在癌症和老化中的作用。
关键词: 老化,细胞凋亡,癌症,细胞衰老,压力,治疗。
图形摘要
Current Drug Targets
Title:Roles of Apoptosis and Cellular Senescence in Cancer and Aging
Volume: 17 Issue: 4
Author(s): Claudia Cerella, Cindy Grandjenette, Mario Dicato and Marc Diederich
Affiliation:
关键词: 老化,细胞凋亡,癌症,细胞衰老,压力,治疗。
摘要: Cancer and aging are two similar processes representing the final outcome of timedependent accumulation of various irreversible dysfunctions, mainly caused by stress-induced DNA and cellular damages. Apoptosis and senescence are two types of cellular response to damages that are altered in both cancer and aging, albeit through different mechanisms. Carcinogenesis is associated with a progressive reduction in the ability of the cells to trigger apoptosis and senescence. In contrast, in aging tissues, there is an increased accumulation of senescent cells, and the nature of apoptosis deregulation varies depending on the tissue. Thus, the prevailing model suggests that apoptosis and cellular senescence function as two essential tumor-suppressor mechanisms, ensuring the health of the individual during early and reproductive stages of life, but become detrimental and promote aging later in life. The recent discovery that various anticancer agents, including canonical inducers of apoptosis, act also as inducers of cellular senescence indicates that pro-senescence strategies may have applications in cancer prevention therapy. Therefore, dissection of the mechanisms mediating the delicate balance between apoptosis and cellular senescence will be beneficial in the therapeutic exploitation of both processes in the development of future anticancer and anti-aging strategies, including minimizing the side effects of such strategies. Here, we provide an overview of the roles of apoptosis and cellular senescence in cancer and aging.
Export Options
About this article
Cite this article as:
Claudia Cerella, Cindy Grandjenette, Mario Dicato and Marc Diederich , Roles of Apoptosis and Cellular Senescence in Cancer and Aging, Current Drug Targets 2016; 17 (4) . https://dx.doi.org/10.2174/1389450116666150202155915
DOI https://dx.doi.org/10.2174/1389450116666150202155915 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Perinatal Management of Fetal Tumors
Current Pediatric Reviews Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry Development of Patents and Clinical Trials on Regenerative Therapy: Gene Therapy
Recent Patents on Regenerative Medicine Tissue Transglutaminase Expression During Neural Differentiation of Human Mesenchymal Stem Cells
CNS & Neurological Disorders - Drug Targets Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma
Reviews on Recent Clinical Trials HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
Current Molecular Medicine Advances in Imaging Gene-Directed Enzyme Prodrug Therapy
Current Pharmaceutical Biotechnology Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Current Pediatric Reviews Store-Dependent Ca2+ Entry in Endothelial Progenitor Cells As a Perspective Tool to Enhance Cell-Based Therapy and Adverse Tumour Vascularization
Current Medicinal Chemistry The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors
Current Cancer Drug Targets Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect
Current Drug Targets Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic Pathways
Current Medicinal Chemistry - Anti-Cancer Agents Cancer and Stem Cells
Current Cancer Therapy Reviews Targeting Transcription Factors for Cancer Therapy
Current Pharmaceutical Design Simultaneous Amplification of HER-2 (ERBB2) and Topoisomerase IIα (TOP2A) Genes - Molecular Basis for Combination Chemotherapy in Cancer
Current Cancer Drug Targets Measurement of Cdk4 Kinase Activity Using an Affinity Peptide-Tagging Technology
Combinatorial Chemistry & High Throughput Screening Pathogenesis and Treatment of Secondary Hyperparathyroidism in Dialysis Patients: The Role of Paricalcitol
Current Vascular Pharmacology